The adverse effect of perioperative brimonidine tartrate 0.2% on flap adherence and enhancement rates in laser in situ keratomileusis patients11The authors have no financial or proprietary interest in any product mentioned in this article.
Authors:
- David D GilbertDGDavid D Gilbert
- 1 August 2001
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 108 (8) , 1434-1438
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Apraclonidine 0.5% Versus Brimonidine 0.2% for the Control of Intraocular Pressure Elevation Following Anterior Segment Laser ProceduresOphthalmic Surgery, Lasers and Imaging Retina, 1999
- Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patientsAmerican Journal of Ophthalmology, 1999
- Effect of Brimonidine Tartrate on Ocular Hemodynamic MeasurementsArchives of Ophthalmology (1950), 1998
- Incidence and management of intraoperative and early postoperative complications in 1000 consecutive laser in situ keratomileusis casesOphthalmology, 1998
- The Efficacy of Brimonidine in Decreasing Elevations in Intraocular Pressure after Laser TrabeculoplastyOphthalmology, 1993